We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$101M
AUM Growth
-$33.2M
Cap. Flow
-$28.8M
Cap. Flow %
-28.64%
Top 10 Hldgs %
54.46%
Holding
93
New
19
Increased
12
Reduced
23
Closed
35

Top Buys

Rank Stock Value
1
UAL icon
United Airlines
UAL
+$3.2M
2
WBD icon
Warner Bros
WBD
+$2.93M
3
PAGS icon
PagSeguro Digital
PAGS
+$2.32M
4
NCLH icon
Norwegian Cruise Line
NCLH
+$2.23M
5
NIU
Niu Technologies
NIU
+$2.04M

Top Sells

Rank Stock Value
1
NVAX icon
Novavax
NVAX
+$10M
2
META icon
Meta Platforms (Facebook)
META
+$9.18M
3
SE icon
Sea Limited
SE
+$3.82M
4
DAL icon
Delta Air Lines
DAL
+$3.06M
5
MU icon
Micron Technology
MU
+$2.8M

Sector Composition

Rank Sector Weight
1 Communication Services 24.16%
2 Industrials 17.67%
3 Technology 17.13%
4 Healthcare 16.59%
5 Consumer Discretionary 13.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIN icon
26
Linde
LIN
$236B
$1.41M 1.4%
4,069
+67
+2% +$21.7K
SE icon
27
Sea Limited
SE
$66.4B
$1.12M 1.11%
4,999
-12,811
-72% -$3.82M
NXST icon
28
Nexstar Media Group
NXST
$6.01B
$1.11M 1.1%
7,359
-476
-6% -$73.8K
EDU icon
29
New Oriental
EDU
$9.32B
$1.06M 1.05%
50,485
-2
-0% -$43
CRM icon
30
Salesforce
CRM
$154B
$1.04M 1.04%
+4,105
New +$1.15M
FATE icon
31
Fate Therapeutics
FATE
$275M
$999K 0.99%
17,066
-2,844
-14% -$161K
TIL icon
32
Instil Bio
TIL
$49M
$867K 0.86%
2,535
+224
+10% +$86.5K
CDAK
33
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$775K 0.77%
69,584
– –
ZTS icon
34
Zoetis
ZTS
$32.7B
$566K 0.56%
2,321
+143
+7% +$31.3K
DIDI
35
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$559K 0.56%
112,181
– –
IPSC icon
36
Century Therapeutics
IPSC
$364M
$459K 0.46%
28,855
+100
+0.3% +$1.88K
BLUE
37
DELISTED
bluebird bio
BLUE
$401K 0.4%
2,007
-843
-30% -$199K
TSVT
38
DELISTED
2seventy bio
TSVT
$379K 0.38%
+14,766
New +$461K
EXEL icon
39
Exelixis
EXEL
$13.9B
$294K 0.29%
+16,083
New +$308K
SPGI icon
40
S&P Global
SPGI
$124B
$286K 0.28%
607
-13
-2% -$5.95K
NVAX icon
41
Novavax
NVAX
$1.21B
$258K 0.26%
1,806
-58,490
-97% -$10M
SNAP icon
42
Snap
SNAP
$7.96B
$210K 0.21%
4,475
-17,864
-80% -$1.01M
DADA
43
DELISTED
Dada Nexus
DADA
$170K 0.17%
+12,918
New +$249K
PCG icon
44
PG&E
PCG
$39B
$139K 0.14%
+11,457
New +$134K
FIRY
45
Firy Inc
FIRY
$154M
$137K 0.14%
+918
New +$176K
CGC
46
Canopy Growth
CGC
$376M
$121K 0.12%
+1,390
New +$165K
CRON
47
Cronos Group
CRON
$1.07B
$88K 0.09%
22,276
-4,319
-16% -$21.6K
AMWL icon
48
American Well
AMWL
$180M
$83K 0.08%
+685
New +$104K
SIRI icon
49
SiriusXM
SIRI
$11B
$82K 0.08%
+1,287
New +$80.5K
INO icon
50
Inovio Pharmaceuticals
INO
$85.6M
$81K 0.08%
1,349
+479
+55% +$38.4K
1
2
3 4

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q4 2021 Portfolio in Review

As of Q4 2021, Parametrica Management held 93 positions worth $101M, down 25% from $134M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Parametrica Management withdrew a net $28.8M in Q4 2021, closing 35 positions and reducing 23 holdings. Its most notable exit was Vale, an estimated $2.02M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

Against the trend, Parametrica Management opened a new position in Warner Bros worth $2.77M.

  • Parametrica Management's largest Q4 2021 buy was Warner Bros: 117,855 shares worth $2.77M.
  • Parametrica Management added most to United Airlines in Q4 2021, an estimated $3.2M increase.
  • Parametrica Management's biggest Q4 2021 reduction was Novavax, cutting an estimated $10M.
  • Parametrica Management fully exited Vale in Q4 2021, selling an estimated $2.02M.
  • Parametrica Management's ten largest holdings make up 54% of its $101M portfolio in Q4 2021.
  • Parametrica Management opened 19 new positions and closed 35 in Q4 2021.
  • Parametrica Management's portfolio value fell 25% quarter-over-quarter to $101M.

Based on Parametrica Management's 13F filing for Q4 2021, filed 15 Feb 2022.